Alison O'Neill
2021
In 2021, Alison O'Neill earned a total compensation of $1.2M as Chief Medical Officer at Surface Oncology, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $199,400 |
|---|---|
| Option Awards | $586,360 |
| Salary | $437,123 |
| Other | $13,151 |
| Total | $1,236,034 |
O'Neill received $586.4K in option awards, accounting for 47% of the total pay in 2021.
O'Neill also received $199.4K in non-equity incentive plan, $437.1K in salary and $13.2K in other compensation.
Rankings
In 2021, Alison O'Neill's compensation ranked 8,014th out of 12,415 executives tracked by ExecPay. In other words, O'Neill earned more than 35.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,014 out of 12,415 | 35th |
Division Manufacturing | 3,547 out of 5,505 | 36th |
Major group Chemicals And Allied Products | 1,577 out of 2,375 | 34th |
Industry group Drugs | 1,402 out of 2,096 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 313 out of 449 | 30th |
Source: SEC filing on April 26, 2022.
O'Neill's colleagues
We found three more compensation records of executives who worked with Alison O'Neill at Surface Oncology in 2021.